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Background: Cystic Fibrosis (CF) is a severe genetic disorder that is common among the Caucasian population. Bacterial respiratory infections are
the main cause of morbidity and mortality in CF patients. Pseudomonas aeruginosa is the main pathogen of lower airways (LAW) decline.
Method: To understand chronic broncho-pulmonary colonization, a systematic review is conducted. The aim of our article is to identify the
pathways of contamination in the upper aero-digestive tract.
Results: A large number of articles report that P. aeruginosa is established ﬁrst at nasopharyngeal sites. The vast majority of authors agree that the upper
aero-digestive tract is the ﬁrst location of colonization by P. aeruginosa and its presence appears to be predictive of subsequent broncho-pulmonary
colonization.
Conclusion: This review supports the possible involvement of the nasal and paranasal sinuses and oral cavity as means of contamination.
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Cystic Fibrosis is one of themost common autosomal recessive
lethal disorders affecting the Caucasian population. The rate in
Brittany, France is 1/3300 births [1]. In 1974, the average age
of death was 8 years due to a lack of appropriate treatment. The
disease is caused by mutations in the cystic fibrosis trans-
membrane conductance regulator (CFTR) gene on the long arm
of chromosome 7, which codes for a transmembrane regulator
protein. More than 1500 mutations have been reported to date
[2]. CFTR mutations result in an abnormal performance of the
cAMP-dependent chloride channel on the apical membrane of
epithelial cells, manifested as dehydrated airway mucus,
disordered cilia-motility and impaired mucociliary clearance
[2–4]. The main clinical manifestations are characterized by
malabsorption, chronic rhinosinusitis and LAW infections. The
natural history of this disease includes acquisition through time of
bacterial species. During early childhood, the broncho-pulmonary
infections are due to Haemophilus influenzae and Staphylococcus
aureus. As the patient grows older, pathogenic Gram-negative
bacteria like Achromobacter xylosoxidans, Burkholderia cepacia
complex and especially Pseudomonas aeruginosa are more
frequently seen. P. aeruginosa is a turning point in the respiratory
disease and its prevalence increases with age [5]. Before arriving to
the lungs, these respiratory pathogens cross different anatomical
areas like the nose and paranasal sinuses on the one hand, and
the oral cavity on the other converging in the oropharynx. The
pharynx is a transition zone and an intersection between the
respiratory tract and digestive tract.
Initially, P. aeruginosa colonizes the lungs intermittently,
and after rapid adaptation, it turns into chronic infection [2,6].
Chronic airway infection with P. aeruginosa and bronchiectasis
are the major causes of morbidity and subsequent mortality in
CF patients [7,8]. Once established in the lungs, this organism
is extremely difficult to eradicate.
P. aeruginosa and especially the mucoid strains are respon-
sible for lung decline in CF patients. There is a vicious circle due
to local inflammation caused by this bacterium that causes lesions
in CF patients generating a loss of respiratory function [9].
This ubiquitous aerobic bacterium is noted for its environ-
mental versatility. In contrast to many environmental bacteria,
P. aeruginosa rarely causes infection in healthy individuals but
it has a remarkable capacity to cause disease in susceptible
hosts. This bacterium is an opportunistic pathogen associated
with respiratory tract infections, causing nosocomial infections in
hospitalized and immunocompromised patients who are mechan-
ically ventilated [6].
P. aeruginosa possesses several factors that contribute to
colonization and chronic infections, in particular the capacity
to form biofilm composed of exopolysaccharides as well as
host mucin and water up to 97%. The initial step is the biofilm
adhesion to a surface. In CF, epithelial mucus accumulation
facilitates this process. This biofilm is found in different parts of
the body. Colonized lungs with presence of biofilm confer to this
bacterium a large resistance to antibiotics and reduce the immune
response of patients. Bacteria populations organized in biofilm are
more difficult to eradicate [6].Often, this bacterium changes its morphology. It becomes
immobile, decreases the production of virulent factors, changes
its lipopolysaccharide (LPS) structure [3] and becomes a mucoid
strain [6,10]. In addition, P. aeruginosa isolates in chronically
infected patients are phenotypically different from those isolates
in other patients (in ventilator-associated pneumonia patients and
patients with acute respiratory failure) or from those in the
environment. It can produce several pigments, a blue-green
pigment pyocyanin, a fluorescent yellow-green pigment and a
brown-red pigment pyomelanin.
Others factors implicated in colonization are surface compo-
nents, the polar pili for eukaryotic cell attachment; flagella
expression in initial stages; and the type III secretion system, the
major virulence factor that allows bacteria to inject toxins into
host cells. One of the secreted proteins is ExoU that causes
damage to cellular membranes and rapid necrotic death. Another
factor is P. aeruginosa Quorum Sensing (cell-to-cell signaling),
a density-dependent system that coordinates gene expression
by the production of small diffusible molecules such as acyl
homoserine lactones (AHL). Some of interconnecting genes are
implicated in biofilm formation, making conditions favorable for
bacterial multiplication and survival and formation of structured
communities.
Persistence of P. aeruginosa colonization is due to the genetic
flexibility provided by its large genome [6]. The large proportion
of hypermutable strains favors adaptation. This hypermutable
character is generated when the rate of spontaneous mutation is
100–1000 times higher than usual.
Mutation development favors bacterial persistence with a
higher resistance to antibiotics because of the large amount of
antimicrobial treatments in CF patients. The presence of 43%
hypermutable P. aeruginosa in CF patients has been demon-
strated [10].
In VAP, P. aeruginosa causes a mortality rate of 34–48%,
due to damage of the epithelium associated with endotracheal
intubation that favors bacterial colonization of the endotracheal
tube and upper respiratory tract. In immunosuppressed patients,
transplant recipients, cancer and neutropenia, the risk of acquiring
P. aeruginosa is increased, with a mortality rate of 40% in
P. aeruginosa associated pneumonia.
The aim of our study is to systematically review the different
pathways of P. aeruginosa in the upper aero-digestive tract
implicated in chronic LAW colonization to better understand
the stages of colonization.
2. Methods
2.1. Search strategy
In November 2013, we conducted a literature review searching
in electronic databases and scanning reference lists in PubMed to
identify studies with P. aeruginosa human colonization data. We
searched in English, Spanish and French languages. We used
the keywords, Mesh terms, synonyms: P. aeruginosa, CF, nose,
paranasal sinus, oral cavity, saliva, upper airways (UAW) and
LAW to find studies, case reports relating association of these
search terms.
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The titles and abstracts of all identified studies were screened
and reviewed to identify potential studies or case reports with
P. aeruginosa impacting on health. Articles with inaccessible
abstracts and conclusions not concordant with article titles were not
used. Only articles helping to understand P. aeruginosa implica-
tion in upper aero-digestive tract and its potential consequences in
CF patients were considered.
2.3. Data analysis
The studies were grouped by category according to the
following inclusion criteria:
• Cystic Fibrosis
• P. aeruginosa
• P. aeruginosa and nose and paranasal sinuses
• P. aeruginosa and oral cavity (saliva, teeth, periodontum)
• Data published between 1954 and 2013.
The exclusion criteria were as follows:
• Cystic Fibrosis on animal models
• Cystic Fibrosis and other bacterial pathogens.
Our aim was to identify the origin of P. aeruginosa in Cystic
Fibrosis: nose, paranasal sinuses and oral cavity.
3. Results
3.1. Article research
Data analysis was performed by ranging articles every ten
years with selected keywords. We found 18,446 CF articles
between 1954 and 2013 and 1057 including P. aeruginosa
keywords. We focused on the theme of our research and grouped
according to the year and the number of keyword articles. AFig. 1. Evolution of the number of international pgraph (Fig. 1) showing evolution of publications is reported
throughout the assessed years.
For a better understanding, we compiled in a table (Table 1)
the most relevant articles and identified the topic (CF or not),
type of study, number of patients included, methods used and
conclusions.
3.2. P. aeruginosa, nose and paranasal sinuses
Several studies discuss paranasal sinuses and bacterial
colonization. Paranasal sinuses are composed of four paired
air-containing cavities around the nasal cavity: maxillary sinuses
on either side, frontal sinuses above ocular cavities, ethmoid
sinuses between the eyes, and behind the ethmoid sinus, and the
sphenoid sinuses.
Several authors report an increased incidence of paranasal
sinus inflammation associated with hypoplasia of these air-
containing cavities [11].
Foremost, Woodworth et al. showed that sinus hypoplasia is
correlated to the CF genotype. In their retrospective study, 31 of 45
CF patients had sinus surgery. And, in this cohort, 25 homozygous
F508del-CFTR had a significantly increased frequency of under-
developed frontal, maxillary, and sphenoid sinuses when com-
pared with other mutations [12].
Eggesbo et al. analyzed, in a case control study, the volume of
sphenoid sinuses in 96 CF patients with median age of 19 years
versus 130 control population with median age 32 years byX-ray
computed tomography. They concluded that CF patients with
two confirmed mutations had significantly smaller sphenoid
sinuses than in controls [13]. In another study in 2002, Eggesbo et
al. including 108 CF patients (median 18 years) and 79 controls
(median 31 years) conclude that reduced mucociliary clearance,
due to high mucus viscosity results in different sinonasal in-
flammatory patterns such as higher rate of sinonasal polyposis,
sphenoethmoid recess and ostiomeatal complex patterns in CF
patients [14].
Sinonasal anatomy in CF patients usually differs from non
CF patients. Chronic rhinosinusitis (CRS) and nasal polyposis
are hallmarks in the CF population [11,15]. Nasal polyposis is aublications by topic between 1954 and 2013.
Table 1
Literature data on UAW manifestations of CF patients.
Ref. Researchers Interest Year Study type Number of patients Sampling and/or methods Results and relevant conclusions
4 Digoy G.P. et al. CF paranasal sinuses 2012 Retrospective chart
study
51 CF children
(age b 18 years)
Cultures from the maxillary
sinuses obtained during
endoscopic sinus surgery
Staphylococcus aureus was the most common
isolate found in the maxillary sinuses in children
with CF, followed by Pseudomonas aeruginosa
and Haemophilus influenzae
11 Gentile V.G. et al. Sinusitis in CF 1996 Prospective
longitudinal study
19 CF children Computed tomography of
paranasal sinuses
There are 2 distinct patterns of sinus disease:
chronic sinusitis and polyposis
12 Woodworth B.A. et al. CF paranasal sinuses 2007 Retrospective review 45 CF patients
(median 32 years)
Computed tomography of
paranasal sinuses
CF patients homozygous for the delta F508 mutation
have a greater incidence of hypoplastic or
underdeveloped sinuses
13 Eggesbo H.B. et al. CF sinuses 1999 Transversal case
control study
96 CF patients
(median 19 years) vs 130
controls subjects (median
32 years) with inflammatory
sinonasal disease
Computed tomography of
paranasal and sphenoid
sinuses
Hypoplasia of the sphenoid sinuses is a characteristic
finding in CF patients.
14 Eggesbo H.B. et al. CF paranasal sinuses 2002 Prospective transversal
case control study
108 CF patients
(median 18 years) vs. 79
controls subjects (median
31 years) with paranasal
sinus diseases
Computed tomography
of paranasal sinuses
CF patients had more widespread sinonasal
inflammatory changes and more advanced
disease for each sinus. Most of them displayed
polyposis and sphenoethmoid recess patterns.
Inflammatory paranasal sinuses is caused
by the impaired mucociliary clearance in CF
15 Anaes K. CF bacterial sinusitis 2013 Prospective longitudinal
study
nonspecificated Functional endoscopic sinus
surgery (FESS), culture
methods
Sinuses can be a focus for initial lung colonization
and infection, sinus inflammation facilitates
persistence of bacteria.
17 Berkhout M.C. et al. UAW bacteriology in CF 2013 Cross sectional study 104 CF patients UAW samples obtained by
nasal lavage and middle
meatal swabs. LAW samples
obtained by expectorated
sputum or cough swabs.
Cultural methods
UAW and LAW cultures showed one or more
concordant microorganism in 50% of the patients.
Pseudomonas aeruginosa was most frequently
cultured from the UAW.
18 Mainz J.G. et al. Clonal relatedness
between CF UAW and
CF LAW isolates
2009 Prospective transversal
study
182 CF patients
(median 17 years)
UAW sampled by nasal
lavage, and LAW by
expectorated sputum and
deep nasal swabs. 16
SNPs typing
23 of 24 CF patients carried identical
Pseudomonas aeruginosa SNP genotypes and 31
of 36 CF patients carried Staphylococcus aureus
spa in UAW and LAW, suggesting that the UAW
play a role as a reservoir in CF
19 Shapiro E.D. et al. Sinuses bacteriology
in CF
1982 Observational study 20 CF patients
(median 15 years)
Ultrasound, radiography, and
transantral sinus aspiration.
Cultural methods
The organisms most commonly recovered from
the sinus aspirates were Pseudomonas aeruginosa,
Haemophilus influenzae, streptococci and
anaerobes.
There was no association between the sinonasal
bacterial species and the predominant bacterial
species in the nasopharyngeal, throat, or sputum
culture.
20 Franche G.L. et al. Nasal bacteriology
in CF
2007 Cross sectional
prospective study
23 CF children
(age 5 years)
Middle meatus aspiration by un
endoscope. Cultural methods
The presence of Pseudomonas aeruginosa was
observed in 18.18% of the positive cultures, and
Staphylococcus aureus was observed in 27.28%.
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Table 1 (continued)
Ref. Researchers Interest Year Study type Number of patients Sampling and/or methods Results and relevant conclusions
The great majority of the middle meatus aspirates of
the patients with cystic fibrosis were negative.
21 Muhlebach M.S. et al. Sinuses bacteriology
in CF
2006 Prospective study 25 CF patients
(median 9,5 years)
Sampling was made using a sterile
rayon culturette during sinus surgery,
oropharyngeal swabs and
bronchoalveolar lavage. Cultural
methods and PFGE
Bacterial sinus infection was present in 96%, caused
by Staphylococcus aureus (49%), Pseudomonas
aeruginosa (42%), and Haemophilus influenzae
(22%). Bacterial species were the same in sinus and
OP or BALF samples of 12 patients of these bacteria
83% showed
22 Mainz J.G. et al. Pseudomonas aeruginosa
in CF lungs
2012 Case reports 2 CF patients (20 years)
with double lung
transplantation (LTX) due
to Pseudomonas aeruginosa
related pulmonary
destruction
Nasal lavage analyzed by
custom-made microarray
It demonstrated persistence of identical
Pseudomonas aeruginosa genotypes UAW prior
to and after LTX underlining risks of descending
colonization of transplanted lungs with
Pseudomonas aeruginosa
23 Hansen SK et al. Pseudomonas aeruginosa
in CF paranasal sinuses
2012 Longitudinal study 46 CF children Expectoration, endolaryngeal
suction, BAL and functional
endoscopic surgery
Paranasal sinuses constitute an important niche for
the colonizing bacteria in many patients
26 Charlson E.S. et al. Lung bacteriology 2012 Prospective transversal
study
6 patients undergoing
clinical bronchoscopy
Oral wash of the oropharynx and
bronchoalveolar lavage. PCR
amplification and pyrosequencing
BAL sample contains substantial oropharyngeal
bacteria. These sampling methods allow
identification of microbes that can replicate in the
lung despite the background due to oropharyngeal
microbes derived from aspiration and bronchoscopic
carry-over.
27 Scannapieco F.A.
et al.
Bacterial respiratory
pathogens in the oral
cavity in care unit patients
2009 Prospective longitudinal
case–control study
146 mechanically-ventilated
patients (median 48 years):
(47 patients under
chlorhexidine treatment
1 day; 50 patients under
chlorhexidine treatment
2 day vs. 49 controls)
Dental plaque samples were collected
with a sterile stainless steel curette
or sterile swab and tracheal samples
with a sterile suction catheter at
admission
and every 48 h until discharge.
Cultural methods
While decontamination of the oral cavity with
chlorhexidine did not reduce the total number of
potential respiratory pathogens, it did reduce the
number of S. aureus in dental plaque of trauma
intensive care patients.
29 Heo S.M. et al. Bacterial respiratory
pathogens in the AUW
et LAW in hospitalized
patients
2008 Prospective longitudinal
study
30 patients with suspected
Ventilator-associated
pneumonia (VAP)
Supragingival dental plaque samples
were collected with a sterile curette
or sterile swab, tracheal samples
with a sterile suction catheter and
bronchoalveolar lavage at admission
and every 48 h until discharge. PFGE
and MLST
Plaque and lung respiratory pathogens are often
genetically indistinguishable; this provides
convincing evidence that dental plaque serves as an
important reservoir for respiratory pathogens
30 Perkins S.D. et al. Ways of lungs
colonization by oral
pathogens
2010 Retrospective
transversal
study
8 mechanically-ventilated
patients in intensive care
unit (median 17 years)
Bacterial biofilm was collected to
endotracheal tubes (ET). Bacterial
community identification by
quantitative PCR and gene surveys
targeting 16S rRNA genes
Study shows that potentially pathogenic bacteria
existed in ET tube biofilms within 24 h incubation.
In the ET tube that was in place for 23 d, 95% of the
sequences belonged to Pseudomonas aeruginosa.
Harboring such pathogens in ET biofilms may
increase the chance of VAP
31 Rams T.E. et al. Oral cavity as source of
CF lungs infections
1990 Cross sectional study 506 subjects with advanced
adult periodontitis
Subgingival samples were collected
with paper points. Culture method and
identification with API STAPH Tract
Higher prevalence of Staphylococcus aureus in
the 50% of subjects. Subgingival plaque could be
a source of this bacterium for descending infection.
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32 Worlitzsch D. et al. Oral cavity as source
of CF lungs infections
2010 Prospective transversal
case–control study
11 CF patients vs. 11 control Biochemical identification methods of
sputum samples only in CF patients,
and periodontal pockets
In 4 of 9 CF sputum identical facultative anaerobes
(Pseudomonas aeruginosa, Staphylococcus aureus,
Burkholderia cepacia) were found in periodontal
pockets and in sputum. In al l patients identical
obligate anaerobic strains were found in both
compartments
33 Komiyama K et al. Pseudomonas aeruginosa
in CF oral cavity
1985 Observational study 31 CF patients Quantitative cultures of buccal
mucosa,
dorsum of the tongue, saliva,
dental plaque
The dorsum of the tongue gave the highest yield
of Pseudomonas aeruginosa followed by the buccal
mucosa, saliva, and dental plaque. Oral colonization
by the mucoid variants of Pseudomonas aeruginosa
may lead to further colonization in the LAW and
subseque
34 Zuanazzi D. et al. Bacterial respiratory
pathogens in the oral
cavity in hospitalized
patients
2010 Retrospective
transversal study
30 patients undergoing
myocardium
revascularisation surgery
Saliva and biofilm samples obtained
in pre- and post-operative phases.
Bacterial detection by PCR and
culture
Staphylococcus spp. (85.7%) was the most prevalent
bacteria, followed by Pseudomonas spp. (83.8%),
and Acinetobacter spp. (53.3%). The oral cavity
of hospitalised patients harbors high frequencies
of bacterial respiratory pathogens, supporting its
potential role as a reservoir.
35 Fourrier F. et al. Bacteria of dental plaque
in intensive care patients
1998 Prospective
longitudinal study
57 patients in MICU Quantitative cultures of dental
plaque, nasal secretions, salivary
and tracheal aspirates, and urine at
admission (day 0) and every 5 day
until death or discharge.
A high bacterial concordance was found between
dental plaque and tracheal aspirate cultures and
between salivary and dental plaque cultures. In
6 of 21 cases of nosocomial infection, responsible
pathogen was isolated from dental plaque.
36 Scannapieco F.A.
et al.
Bacteria of dental plaque
in intensive care patients
1992 Prospective study 34 medical Intensive Care
Unit (MICU) patients vs 25
preventive dentistry clinic
patients
Quantitative cultures of dental
plaque and buccal mucosa
Bacteria commonly causing nosocomial pneumonia
colonize the dental plaque and oral mucosa of
intensive
care patients. Dental plaque may be an important
reservoir of these pathogens in medical ICU patients
38 Abe S. et al. Bacterial respiratory
pathogens in the oral
cavity in daily nursing
care patients
2001 Case control study 54 subjects (median
75.3 years) in daily nursing
care vs. 21 controls
(median 69.5 years) and
22 controls
(median 25.4 years)
Sterile phosphate buffered
saline lavage during 10 s.
Culture methods,
PCR detection and PFGE.
Professional oral health care for elderly patients
requiring daily nursing plays a significant role in
reducing the numbers of potential respiratory
pathogens in the oral cavity.
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13 years. Polyposis may be responsible for generating a favorable
environment for bacteria pathogen colonization and the exagger-
ated immune response dominated by neutrophils [16].
CRS is a chronic inflammation that is related to anatomical
causes (deviated septum, turbinate hypertrophy), environmental
factors (smoking, humidity), inflammatory and infectious causes
(bacterial, viral and fungal infections, allergies, nasal polyposis),
to immunosuppression and to the presence of nasal sinus tumors
obstructing the natural drainage.
Even if functional factors are unknown, CFTR channels
might be involved in the development of these diseases. CFTR
Cl− ion transport controls the hydration of mucosal surfaces
and promotes effective mucociliary clearance. Association of
viscous mucus, dysfunctional ionic transport in epithelial cell,
damage of mucociliary drainage and inflamed tissues could
explain the mechanical obstruction of the sinus ostia.
This CRS affects the quality of life and may also contribute to
pulmonary exacerbations with the possibility of the microbial
infection descending into CF patient's lungs [17,18].
Although morphological abnormalities of the paranasal sinuses
are present in nearly all CF patients, the microbiology of their
sinuses has gained more attention over the last years.
Shapiro et al., was one of the first authors to publish
concerning bacteriology of maxillary sinuses in CF patients in
1982. 34 aspirations were conducted on 20 CF patients. 95% had
at least one positive culture (≥104 colony-forming units/ml).
The most common organisms were P. aeruginosa, H. influenzae,
Streptococci and anaerobes. No association was found between
bacterial species in nasopharyngeal, throat or sputum culture
[19].
In another study, Franche et al. didn't find a relation between
sputum and middle meatus aspiration cultures. In positive
cultures, they found the presence of P. aeruginosa in 18.2%
and S. aureus in 27.3%. Moreover, a statistically significant
relation was revealed between rhinorrhea and positive cultures of
middle meatus aspiration [20].
Recently, Digoy et al. reported that S. aureus was the most
common bacteria in cultures from the maxillary sinuses obtained
during endoscopic surgery on 51 CF children (withmean age of 9)
followed by P. aeruginosa andH. influenzae [4]. Comparing with
the Shapiro et al. [19] study which showed that P. aeruginosa
is the most common isolate in 15 years old CF patients, we can
submit the hypothesis that bacterial pathogens are frequently
acquired in an age-dependent sequence. Other bacterial patho-
gens were retrieved: Staphylococcus (non-aureus), B. cepacia,
Stenotrophomonas maltophilia, Streptococcus pneumoniae, and
Escherichia coli [4].
Muhlebach et al. reported that P. aeruginosa is the most
prevalent bacteria in sinus aspirations in association with anaerobic
bacteria [21].
Several studies revealed the relation between sinonasal bacterial
colonization and subsequent lung colonization that supports the
idea of bacterial spread from sinuses to LAW [17,19,21].
Muhlebach et al. studied 45 paired sinus-bronchoalveolar
lavage fluid (BALF) cultures of 31CF patients (median 8, 2 years;
range of 3.2–18.7 years). Phenotypically identical cultures wereanalyzed by Pulsed-Field Gel Electrophoresis (PFGE). They
revealed that P. aeruginosa is the most prevalent bacteria in
older CF childrens' sinus cultures and BALF compared to
younger CF children. Interestingly they showed the presence of 2
P. aeruginosa isolates phenotypically different with the same
PFGE pattern, and in 83% of the samples analyzed they showed
identical genotypes in UAW and LAW cultures. This fact could
be explained by a descending infection [21].
Recently, Mainz et al. in 2012, studied the UAW's role
as a reservoir and gateway for acquisition of opportunistic
bacteria, as P. aeruginosa and S. aureus, and subsequent LAW
microbial colonization in CF. They assessed a study including
182 CF patients (median 17 years) (63 chronically colonized
with P. aeruginosa). UAW were sampled by nasal lavage and
LAWby sputa collection and deep throat swabs. UAW and LAW
were positive for P. aeruginosa in 29 and 57 cases respectively,
for a total of 63 patients. Available 16 SNPs typing showed
95.8% genetic identity between UAW and LAW P. aeruginosa
isolates. Finally, the authors concluded that CF UAW are a
reservoir for descending infection to the lung [18].
In a second study, Mainz et al., in 2 CF post lung-transplanted
adults showed that transplanted donor lungs became infected
with identical P. aeruginosa clones previously found in the
explanted lungs, with a high proportion of identical phenotypic
and genetic strains in the sinuses. This finding demonstrates
persistence of identical P. aeruginosa isolates in UAW and the
subsequent lung colonization via UAW descending infection,
supporting results of their first study [22].
Hansen et al., corroborate that paranasal sinuses are a potential
niche for P. aeruginosa clones that allow bacteria to adapt and
subsequently cause chronic lung infection [23].
Later, Berkhout et al. demonstrated, in their study of 104
patients, that P. aeruginosa was the most prevalent pathogenic
bacteria in UAW cultures (48.1%). This pathogen was found in
LAW despite its eradication in UAW (three successive negative
cultures in six months). Even though this bacteriumwas eradicated
in UAW, it was to be a pathogen in LAW [17]. UAW are less
exposed to antibiotics, host immune cells and airflow than
LAW, making an ideal reservoir for bacterial growth through
the heterogeneous conditions [2].
Cramer et al. revealed in a study of 955 P. aeruginosa
isolates, that the P. aeruginosa population is genotypically
composed by a few ubiquitous clones (environment and human
disease habitats contain twenty most common clones). In CF
patients, five of these 20 most common clones are found [3].
So, detection and recognition of sino-nasal flora are useful to
know the potential role of this UAW reservoir for bacterial
pathogens in order to treat it rapidly and prevent chronic lung
colonization.3.3. P. aeruginosa and oral cavity
The oral cavity is an anatomical complex region comprising
different tissues. It is composed of a maxilla and a mandible
where teeth are found, the supporting tissues of the tooth called
periodontal tissues. The inner faces of the cheeks come on each
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bathed in saliva.
The mouth is continuously colonized by hundreds of different
micro-organisms on different surfaces: teeth, dorsum of the
tongue, and oral mucosa that constitute oral biofilm. Dental plaque
consists of at least 800 bacterial species [24] and serves as a
permanent reservoir of microorganisms that are not usually in the
normal oral microbiote such as potential respiratory pathogens
(PRPs).
Moreover, there is modification of the oral microbiote
depending on the state of health of patients. For example,
S. aureus, S. pneumoniae, Acinetobacter baumannii,H. influenzae
and P. aeruginosa become predominant and constitute a more
aggressive flora in critically ill patients [25]. Before entering the
broncho-pulmonary tree, it is clear that the oral cavity and
oropharynx are first colonized by these PRPs.
Very few articles were reported for P. aeruginosa presence
in the oral cavity of CF patients. This section aims to show that
some anatomical sites or physiological conditions (periodontal
tissues, dental plaque and saliva) will be a potential niche for
PRPs including P. aeruginosa.
Several studies of intensive-care unit and hospitalized patients
reveal that dental plaque is an important reservoir for PRPs, as
S. aureus and P. aeruginosa. Supragingival biofilm samples show
the presence of bacteria able to cause nosocomial pneumonia,
caused by aspiration of oropharyngeal or UAW bacteria [26].
Moreover, dental plaque bacteria can be released in the saliva and
then, aspirated into the LAW causing infections [27].
For patients who receive mechanical ventilation in intensive
care units, it's well known that the lack of oral hygiene by
mechanical tooth-brushing allows increased microbiote diver-
sity and quantity. Some papers report the impact of 0.12%
chlorhexidine gluconate (CHX) oral rinse, as Scannapieco et
al., for the decontamination of the oral cavity. This oral rinse
inhibits the viability of planktonic bacteria found mostly in
saliva. However, its action is very limited on the biofilm and in
the Scannapieco et al. study, CHX did not reduce the numbers
of Gram-negative bacteria in oral biofilm [27].
Abe et al. determined the effectiveness of oral care performed
by health professionals in reducing aspiration pneumonia. Three
groups constitute the cohorts: 54 patients N65 years requiring
daily care, 21 patients N65 years in good health, and 22 patients
b30 years in good health. They examined the prevalence of
respiratory pathogens in samples of gargle by culture and PCR. In
the group of elderly people in institutions, microbes found in
descending order areC. albicans, S. pneumoniae, Staphylococcus
spp., S. aureus methicillin-resistant, and P. aeruginosa. The
numbers of C. albicans cells recovered in samples from elderly
subjects were significantly higher than those recovered from the
healthy young group. Elderly patients needing daily care and
receiving professional oral health care had lower prevalence and
cell numbers of C. albicans than did the elderly patients without
such oral care. This study showed that professional oral health
care in elderly requiring daily nursing care reduced the cell
numbers of PRPs [28].
Heo et al. demonstrated in 2008 that PRPs taken in dental
plaque are genetically identical to strains from BALF in patientswho were under mechanical ventilation with VAP. Other findings
demonstrated strong correlations between oropharyngeal coloni-
zation and positive BALF samples [29].
Different authors explain that in VAP, the endotracheal tube,
which is an artificial surface, to which bacteria adhere and form
colonies resulting in the formation of biofilm, bypasses the
anatomical barriers (between the trachea and oropharynx) and
facilitates the transport of bacteria from the oral cavity into the
lungs. It is recognized that Streptococcus spp. belonging to the
normal oral microflora promote recruitment of bacteria in dental
plaque through production of extracellular glucans and permit
coaggregation to other microbes. So, they start the colonization
process [30].
In addition to this aspect of coaggregation, disease of the
supporting tissues called periodontal disease, influences lung
infections. To enhance this point of view, cross sectional studies
on oral S. aureus prevalence determined a higher prevalence rate
of this bacterium in the 50% of patients with periodontal disease
in comparison to healthy people [31].
Worlitzsch et al. investigated the role of periodontal pockets as
a possible source for CF lung infections in a case control study
with 22 patients. Facultative anaerobes such as P. aeruginosa,
S. aureus and B. cepacia and obligate anaerobes such as
Prevotella spp., Propionibacterium spp. and Actinomyces spp.
were found respectively for 44.4% and for 100% both in
periodontal pockets and sputum. So, they conclude that the
periodontal pocket is a source of broncho-pulmonary infection
[32].
In addition, P. aeruginosawas investigated at different sites of
the oral cavity (dorsum of the tongue, dental plaque, and saliva)
and sputum from 31 CF patients. In their study, the dorsum of the
tongue is where P. aeruginosa is the most frequently detected
followed by oral mucosa, saliva and dental plaque. For the
authors, oral colonization by P. aeruginosa may lead to future
UAW colonization [33].
Regarding the study of Charlson et al. that analyzed oral
wash (OW) and BALF in 6 patients with lungs disease, BALF
and OW samples in 5 patients presented the same types of bacteria,
with a high prevalence of Prevotella spp. and Streptococcus spp.
One of lung transplanted patients showed a higher prevalence of
Streptococcus spp. and Rothia spp. in OW; and BALF sample was
dominated by P. aeruginosa [26]. This data suggests that there is
first a change in the microbial community composition among
patients colonized and non-colonized with P. aeruginosa. And
secondly, the microbial community in OW and BALF changes in
relation to presence of P. aeruginosa.
According to saliva contamination, Zuanazzi et al. demon-
strated the presence in high proportion of PRPs in oral cavity of
hospitalized patients. They evaluated the prevalence of oral
colonization by PRPs (Acinetobacter spp., Pseudomonas spp.,
S. aureus and Dialister pneumosintes) in 30 patients who
underwent cardiovascular surgery. An oral clinical exam was
performed at the beginning of this research protocol. Saliva and
biofilm samples were obtained before and after surgery (after
orotracheal extubation).
Thirteen were edentulous (ED) and 17 were dentate (DE),
with moderate chronic periodontitis. The most prevalent bacteria
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Pseudomonas spp., and Acinetobacter spp. In plaque samples,
DE with N14 teeth showed a significantly higher prevalence
of Pseudomonas spp. than individuals with ≤14 teeth. A strong
correlation between the presence of Acinetobacter spp. and
Pseudomonas spp. was observed [34].
It appears that mouth tissue and the presence of humidity are
portals of entry for respiratory pathogens and their arrival in the
LAW. Fourrier et al. showed that bacteria causing pneumonia are
first found in dental plaque [35] and in addition Scannapieco et al.
revealed that the use of antibiotics modifies oral microbiote and
favors oral colonization with respiratory pathogens [36]. This
fact can explain bacterial colonization in CF patients, who are
continuously treated by antibiotics.
4. Conclusion
This literature review highlights the presence of PRPs like
P. aeruginosa in the nose and paranasal sinuses but also in the
oral cavity and oropharynx.
Their presence constitutes a continuing risk of chronic lung
recontamination. Paranasal, oral and oropharyngeal microbiote
could play a possible role in the pathogenicity ofP. aeruginosa and
contribute to its establishment in the LAW. However, mechanisms
of pathogen acquisition and persistence in CF LAW are not well
elucidated, thereby limiting the prevention of lung descending
infection.
Unfortunately, there is a lack of longitudinal studies to clarify
whether P. aeruginosa is a transient member of the oral flora
in chronically broncho-pulmonary colonization in CF patients.
Future studies are needed in this CF population, to learn about the
prevalence of P. aeruginosa, the genotype concordance with P.
aeruginosa lung colonization on the one hand and on the other
hand to understand the presence of oral bacteria like periodontal
bacteria in the LAW in these patients and their interactions with
this principal pathogen.
Considering the possible role of the upper aero-digestive
airway as a reservoir for lung infections with pathogens such as
P. aeruginosa, protocols of sampling for bacteriological
analysis should be optimized to prevent passage of oral and
nasal bacteria into the LAW. Early bacterial detection in the
upper aero-digestive airway and subsequent adaptive treatment
for eradication could improve the success in preventing LAW
colonization. Future investigations of sampling by non-invasive
methods of the upper aero-digestive airway (like collection of
saliva) would be interesting.
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